Beijing Konruns Pharmaceutical Co.,Ltd.
Status: Publicly traded
Direct answer
Beijing Konruns Pharmaceutical Co.,Ltd. is publicly traded on SHH under the ticker 603590.SS.
Beijing Konruns Pharmaceutical Co.,Ltd., a Chinese company established in 2003 and based in Beijing, focuses on the discovery, production, and distribution of various pharmaceutical items. Among its key offerings is Su Ling, a hemagglutinin preparation designed to minimize blood loss during surgical procedures and manage post-operative bleeding. The firm is also actively developing a pipeline of potential new...
Can you invest in Beijing Konruns Pharmaceutical Co.,Ltd.?
Yes. Beijing Konruns Pharmaceutical Co.,Ltd. trades publicly on SHH as 603590.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Beijing Konruns Pharmaceutical Co.,Ltd.
Detailed equity research is provided by MarketSnap.